Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2011

Open Access 01-05-2011 | Clinical Practice: Clinical Images

It’s Not Behçet’s!

Authors: Yen Chen Liu, BS, Amisha Desai, MD, Bryan Lee, MD, Malathi Srinivasan, MD

Published in: Journal of General Internal Medicine | Issue 5/2011

Login to get access

Excerpt

A healthy 28 year-old man with isolated oral candidiasis at 17 and 26 years, on no medications, and having a recent URI 1 week before, presented with acute-onset progressive, painful oral mucositis and odynophagia (Fig. 1). His temperature was 101.6°F. The white blood cell count was 19.5, with 4.4% lymphocytes, 226CD4. Oral nystatin and IV caspofungin were started. Subsequently, the patient developed injected sclera with bilateral subconjunctival hemorrhages (Fig. 2) and marginated, erythematous, targetoid genital papules with vesicular centers (Fig. 3). His oral, ocular and genital lesions corresponded to the classic distribution of Behçet’s syndrome, initially placing this at the top of the differential diagnosis, followed by erythema multiforme (EM) and herpes simplex. However, generalized oral mucositis, conjunctivitis and, most importantly, targetoid lesions are not common in Behcet’s syndrome. Behcet’s syndrome frequently presents with aphthous ulcers sparing the outer lips, genital ulcers and uveitis. Subsequent biopsy of the targetoid lesions demonstrated EM, with vacuolizing keratinocytes and tagging lymphocytes. Skin lesions and pain resolved after 1 week of high-dose methylprednisolone without complications. Repeat complete blood count (CBC) showed resolution of the lymphocytopenia. EM is a self-limited hypersensitivity reaction to external triggers, most notably HSV, Mycoplasma pneumoniae and medications1,2. In this patient, HIV, HSV, M.pneumonia and Legionella studies were negative. Traditionally, EM has been placed within the hypersensitivity reaction spectrum, which includes Stevens-Johnson syndrome and toxic epidermal necrolysis3. However, there is suggestive evidence that EM may be a distinct entity. Treatment targets underlying infection and removing offending agents. Currently, systemic steroids are frequently used, but remain controversial.
Literature
1.
go back to reference Ayangco L, Rogers RS III. Oral manifestations of erythema multiforme. Dermatol Clin. 2003;21:195–205.PubMedCrossRef Ayangco L, Rogers RS III. Oral manifestations of erythema multiforme. Dermatol Clin. 2003;21:195–205.PubMedCrossRef
2.
go back to reference Volcheck GW. Clinical evaluation and management of drug hypersensitivity. Immunol Allergy Clin North Am. 2004;24:357–71.PubMedCrossRef Volcheck GW. Clinical evaluation and management of drug hypersensitivity. Immunol Allergy Clin North Am. 2004;24:357–71.PubMedCrossRef
3.
go back to reference Williams PM, Conklin RJ. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am. 2005;49:67–76.PubMedCrossRef Williams PM, Conklin RJ. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am. 2005;49:67–76.PubMedCrossRef
Metadata
Title
It’s Not Behçet’s!
Authors
Yen Chen Liu, BS
Amisha Desai, MD
Bryan Lee, MD
Malathi Srinivasan, MD
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 5/2011
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1546-z

Other articles of this Issue 5/2011

Journal of General Internal Medicine 5/2011 Go to the issue

Healing Arts: Materia Medica

Transitions in Care